.
MergerLinks Header Logo

New Deal


Announced

Bohui Innovation Biotechnology to acquire Interchim.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

France

reagents

Friendly

Pending

Pharmaceuticals

Majority

Single Bidder

consumables

Private

Merger

Cross Border

Synopsis

Edit

Bohui Innovation Biotechnology, a manufacturer of biomedical products, agreed to acquire Interchim Group, a provider of chromatography and purification instrumentation and consumables for life sciences, research and industry. Financial terms were not disclosed. This transaction will subsequently result in the combination of Bohui's subsidiary Advion, a company specializing in high performance, small footprint mass spectrometry, and Interchim. "We are really excited about the perspective of this strategic combination. As a guarantee of a promising future, it represents today for Interchim, its employees, suppliers and partners a perfect fit. The strengths of the two entities, already working together successfully, will be enhanced by this new step and will enable us to reach and develop unparalleled scientific solutions and technological platforms for our customers around the world," Lionel Boch, Interchim Chairman.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US